Shots:

• Vanda will collaborate with UW Medicine and its Virology Lab on a pharmacogenetics study in patients with COVID-19. The study will focus on the sequencing of the genome of individual patients- as well as the COVID-19 virus- and the identification of genetic factors that correlate with disease progression and outcomes
• To support the study- Vanda and UW Medicine plan to collect WGS data from 1-000+ patients with COVID-19 infection and perform Viral Genome Sequencing- which enables them to explore host susceptibility- associations of WGS with clinical outcomes and severity of the disease- as well as host-virus interactions
• The study is expected to initiate the enrollment in the coming weeks and will be open to patients in hospitals and clinics around the US

Click here ­to­ read full press release/ article | Ref: Vanda | Image: Vanda